No evidence for an effect of the CCR5 delta32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HIV)-1 disease progression among HIV-1-infected injecting drug users.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples